Smith & Nephew plc (FRA:NPW1)

Market Cap	11.53B -15.3%
Revenue (ttm)	5.52B +6.0%
Net Income	556.77M +29.3%
EPS	0.66 +31.8%
Shares Out	n/a
PE Ratio	19.42
Forward PE	13.36
Dividend	0.34 (2.65%)
Ex-Dividend Date	Oct 1, 2026

Volume	n/a
Open	12.90
Previous Close	13.00
Day's Range	12.90 - 12.90
52-Week Range	11.60 - 16.14
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 5, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1856
• Employees: 17,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: NPW1

Financial Performance

In 2025, Smith & Nephew's revenue was $6.16 billion, an increase of 6.09% compared to the previous year's $5.81 billion. Earnings were $625.00 million, an increase of 51.70%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 23, 2026

Data Sources Report a data error